BI & PXS Nash drug still has the potential to be the "Best in Class" Nash drug and this would be significant . Most advanced drug in NASH area is now Intercept´s (ICPT) Ocaliva but the drug has horrible side effects and weak efficacy another potential competitor is Gilead but their drug failed in late stage trials .There are other 2 companies (Genfit & Madrigal) who will report Phase 3 data in short term but i think these drugs will fail too .
Intercept, Intercepted Before The NASH Goal Line
https://seekingalpha.com/article/4276067-intercept-intercepted-nash-goal-line
- Forums
- ASX - By Stock
- NASH Phase 2 results imminent --A $20+ BILLION Market
BI & PXS Nash drug still has the potential to be the "Best in...
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.002(9.09%) |
Mkt cap ! $28.65M |
Open | High | Low | Value | Volume |
2.2¢ | 2.5¢ | 2.2¢ | $12.04K | 509.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 82668 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 82668 | 0.023 |
2 | 338839 | 0.022 |
5 | 1736248 | 0.021 |
12 | 2826008 | 0.020 |
2 | 999988 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 100000 | 1 |
0.025 | 100000 | 1 |
0.026 | 50000 | 1 |
0.027 | 200000 | 1 |
0.028 | 500000 | 1 |
Last trade - 15.57pm 28/06/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online